Article
A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection
9 Aug 2025
Abstract excerpt
Monkeypox virus (MPXV) has re-emerged globally since May 2022, posing a significant public health threat. To address this, we develop two multivalent mRNA vaccine candidates—AAL, encoding three MPXV antigens, and AALI, which combines AAL with an immune-enhancing IFN-α protein. Both vaccines are delivered via mannose-modified lipid nanoparticles to target dendritic cells. Here we show that these vaccines elicit...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
